Olympus (OTCMKTS:OCPNY) Stock Rating Lowered by Zacks Investment Research

Olympus (OTCMKTS:OCPNY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports.

According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “

Olympus stock opened at $22.31 on Wednesday. Olympus has a 1 year low of $18.12 and a 1 year high of $24.26. The business has a 50-day moving average of $22.06 and a 200-day moving average of $21.20. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.24 and a current ratio of 1.82.

About Olympus

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment.

See Also: Hedge Funds Explained

Get a free copy of the Zacks research report on Olympus (OCPNY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.